-transparent.png){kind=logo}
Patients with rheumatic diseases often have circulating autoantibodies to nuclear components. The clinical significance of the antibodies is controversial, although in some cases they are valuable in the diagnosis of the disease. This report presents results of a study of Scl-70, an autoantigen recognized by sera of many patients with the most severe form of progressive systemic sclerosis. It was possible to show, by three independent criteria, that Scl-70 is the abundant nuclear enzyme DNA topoisomerase I. Therefore, antibody probes of high titer and high affinity are now available for the study of this important nuclear enzyme.
Related Publications
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
January 1986,
Chromosoma,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
August 1990,
Experimental cell research,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
October 1990,
Arthritis and rheumatism,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
June 2010,
Nihon rinsho. Japanese journal of clinical medicine,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
December 1986,
FEBS letters,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
December 1990,
Clinical immunology and immunopathology,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
November 1999,
Nihon rinsho. Japanese journal of clinical medicine,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
October 1990,
The Journal of rheumatology,
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
June 2009,
Rheumatology (Oxford, England),
J H Shero, and
B Bordwell, and
N F Rothfield, and
W C Earnshaw
October 2022,
Seminars in arthritis and rheumatism,
